Quality Assurance
Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.
22 leveled profiles. Pick a level to see the full profile.
Individual contributor
Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.
Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.
Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.
Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.
Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.
Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.
Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.
Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.
Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.
Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.
Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.
Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.
Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.
Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.
Focuses on validating software quality through test analysis, test case design, and test automation across web, API, and non-functional layers. Distinct from broader Software Engineering (which builds the product) and SRE/Platform reliability (which operates production infrastructure); this function owns risk-based test strategy, defect detection, automation frameworks, and quality outcomes against requirements throughout the SDLC.
Quality engineering and computer system validation for integrated robotic laboratory automation in regulated life-sciences (GxP) environments. Distinct from general software QA in its grounding in GMP/GAMP 5 computer system validation, IQ/OQ/PQ qualification, and hardware-in-the-loop testing of fully integrated robotic workcells (liquid handlers, vision systems, PLCs); distinct from manufacturing/process QA in its focus on the automation software stack, test automation frameworks, and CI/CD-integrated quality gates across the robotics codebase. Spans configuration and unit testing of automation software through end-to-end QA ecosystem ownership and regulatory inspection leadership.
Quality Assurance for a biotechnology Contract Development and Manufacturing Organization (CDMO) operating in a GxP/regulated environment. Distinct from QC analytical testing focus (this is QA oversight of the quality system, not bench testing) and from in-house pharma QA in that it centers on CDMO-specific demands: client/sponsor quality interface, CMO oversight, quality agreements, batch disposition for multiple client products, and hosting client and regulatory inspections. Spans batch record review and disposition, deviation/investigation/CAPA/change control management, QMS ownership, supplier/CMO quality, and regulatory inspection readiness under cGxP, FDA, and ROW frameworks.
Management
Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.
Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.
Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.
Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.
Management of quality assurance and quality control operations spanning inspection, testing, and validation across both manufacturing/product-quality (metrology, SPC, CAPA, QMS standards) and software/test-engineering (test automation, release validation, test architecture) domains. Distinct from sibling focuses such as Regulatory/Compliance Affairs, Supplier Quality, or Reliability Engineering — this focus owns the day-to-day quality control systems, inspection/test teams, defect prevention, and quality signal ownership that gate production and release.